Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2018Cell ReportsOpen Access

The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade

View Full Paper
Ask AI
Bookmark
Share

Authors

DSDavid SchaerBayer (United States)RBRichard P. BeckmannRuhr University BochumJDJack DempseyEli Lilly (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schaer et al. (2018) studied this question.

synapsesocial.com/papers/69fff796b124fe581985b5f7https://doi.org/10.1016/j.celrep.2018.02.053
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Defective Proximal TCR Signaling Inhibits CD8+ Tumor-Infiltrating Lymphocyte Lytic Function2005 · 75 citations
  2. 2Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria2009 · 3,284 citations
  3. 3Characteristics of a Serially Transplanted Mouse Mammary Tumor and Its Tissue-Culture-Adapted Derivative1972 · 402 citations
  4. 4Interferon-γ: an overview of signals, mechanisms and functions2003 · 4,154 citations